list glp-1 drugs Market Overview: Agonists and the Obesity Market | Blog complete list of glp 1
Description
doi: 10.2337/db13-0710
23GT450)
Stolwyk, K
[DOI] [PubMed] [Google Scholar] 221.Holst J.J., Burcelin R., Nathanson E
Novo Nordisk (maker of Wegovy) and Eli Lilly (maker of Zepbound) have agreed to provide these medications at a net price of $245 per month to Medicare, well below their list prices of $1,000+
